KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Progyny (PGNY) Other Non Operating Income (2020 - 2025)

Historic Other Non Operating Income for Progyny (PGNY) over the last 6 years, with Q3 2025 value amounting to $2.4 million.

  • Progyny's Other Non Operating Income fell 5572.31% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.4 million, marking a year-over-year decrease of 4250.21%. This contributed to the annual value of $15.7 million for FY2024, which is 8510.64% up from last year.
  • Per Progyny's latest filing, its Other Non Operating Income stood at $2.4 million for Q3 2025, which was down 5572.31% from $2.7 million recorded in Q2 2025.
  • Over the past 5 years, Progyny's Other Non Operating Income peaked at $5.5 million during Q3 2024, and registered a low of -$293000.0 during Q4 2021.
  • Moreover, its 5-year median value for Other Non Operating Income was $1.9 million (2024), whereas its average is $1.7 million.
  • In the last 5 years, Progyny's Other Non Operating Income plummeted by 147142.86% in 2022 and then surged by 783200.0% in 2023.
  • Over the past 5 years, Progyny's Other Non Operating Income (Quarter) stood at -$293000.0 in 2021, then skyrocketed by 193.86% to $275000.0 in 2022, then surged by 795.27% to $2.5 million in 2023, then dropped by 24.0% to $1.9 million in 2024, then skyrocketed by 30.25% to $2.4 million in 2025.
  • Its Other Non Operating Income stands at $2.4 million for Q3 2025, versus $2.7 million for Q2 2025 and $2.4 million for Q1 2025.